Asymmetric dimethylarginine (adma) inhibits the effect of erythropoietin on endothelial cell migration in a proinflammatory environment
; Maltaneri, Romina Eugenia
; Schiappacasse, Agustina
; Vittori, Daniela Cecilia
; Nesse, Alcira Beatriz 
Otros responsables
Fecha
2019
Editorial
Fundación Revista Medicina
Revista
Título del libro
Nombre del evento
LXIV Reunión Anual de la Sociedad Argentina de Investigación Clínica; LI Reunión Anual de la Asociación Argentina de Farmacología Experimental; XXI Reunión Anual de la Sociedad Argentina de Biología; XXXI Reunión Anual de la Sociedad Argentina de Protozoología; IX Reunión Anual de la Asociación Argentina de Nanomedicinas y VI Reunión Científica Regional de la Asociación Argentina de Ciencia y Tecnología de Animales de Laboratorio
Fecha del evento
2019-11-13
Institución organizadora
Sociedad Argentina de Investigación Clínica
Asociación Argentina de Farmacología Experimenta
Sociedad Argentina de Biología
Sociedad Argentina de Protozoología
Asociación Argentina de Ciencia y Tecnología de Animales de Laboratorio
Asociación Argentina de Nanomedicinas
Asociación Argentina de Farmacología Experimenta
Sociedad Argentina de Biología
Sociedad Argentina de Protozoología
Asociación Argentina de Ciencia y Tecnología de Animales de Laboratorio
Asociación Argentina de Nanomedicinas
ISSN
eISSN
ISBN
Idioma
Inglés
Tipo del evento
Reunión
Clasificación temática
Palabras clave
Resumen
Hyperhomocysteinemia induces vascular endothelial dysfunction, an early hallmark of atherogenesis. Previously, we found a sensitizing effect of the inflammatory cytokine TNF-alpha on a promigratory action of erythropoietin (Epo), which was not observed when the molecule was modified by N-homocysteinylation with homocysteine thiolactone, the reactive derivative of homocysteine. The strong correlation found between hyperhomocysteinemia and levels of asymmetric dimethylarginine (ADMA), the amino acid formed during methylation of proteins, has been considered of interest in endothelial dysfunction. Therefore, the aim of this work was to study whether ADMA accumulation could affect the ability of different factors to induce endothelial cell migration. Wound healing assays of EA.hy926 endothelial cells stimulated by 10% fetal bovine serum (FBS), 20 ng/mL VEGF or Epo+TNF-alpha (80 ng/mL and 30 ng/mL, respectively) were performed in the presence or absence of ADMA (30 or 100 µM). Results are expressed as a percentage of the cell migration obtained in the presence of FBS. FBS: 100; Control: 22.0±2.4; ADMA: 20.1±3.4; *FBS+ADMA30: 66.6±3.5; **FBS+ADMA100: 43.3±3.9; Epo+TNF-alpha: 56.4±1.2; *Epo+TNF-alpha+ADMA30: 37.4±2.9; **Epo+TNF-alpha+ADMA100: 31.1±1.6; VEGF: 44.5±2.9; *VEGF+ADMA30: 30.3±2.1; **VEGF+ADMA100: 19.6±2.8; *P<0.05 and **P<0.01 vs. respective controls, n=4. It can be seen that the inhibition of the promigratory effects of all the factors analyzed was dependent on ADMA concentration. The results of cell viability and MTT assays confirmed that the effects of ADMA on the promigratory action of Epo+TNF-alpha and VEGF cannot be attributed to cytotoxicity or cell proliferation. These results underline the important role of homocysteine in cardiovascular pathophysiology, since increased homocysteine is involved in a direct inhibition of the enzymes responsible for ADMA degradation.
Colecciones
Aprobación
Revisión
Complementado por
Referenciado por
Licencia Creative Commons
Excepto donde se indique lo contrario, la licencia de este ítem se describe como by-nc-sa
